Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients.
The aim of this study was to adjust dry weight by short-term blood volume monitoring (BVM)-guided ultrafiltration and evaluate the effects of optimizing dry weight on blood pressure (BP) control and intradialytic symptoms (IDS) in a group of hypertensive hemodialysis (HD) patients. The study was performed in four sequential phases, each of which lasted for 1 week, on nine hypertensive HD patients (six girls, age 16.9 +/- 3.1 years). In phase I, patients were observed by BVM. In phase II, BVM was used to guide ultrafiltration to adjust dry weight. Antihypertensive drugs were gradually tapered or withheld in phase III, when the patients were hypotensive and/or their IDS increased. In phase IV, this particular weight was maintained without any intervention. Pre- and post-HD body weight, pre-HD, post-HD, 30 min after HD casual BP values, and IDS in each HD session were recorded. The BP was also assessed by 44-h ambulatory BP monitoring (ABPM), which is an ideal method to determine BP changes throughout the interdialytic period at the beginning of phase I and at the end of phase IV. There was a decrease in mean dry weight, all casual systolic BPs, and systolic/diastolic ABPM at the end of the study (all p < or = 0.05). Antihypertensive drugs were stopped in five patients and reduced in two during phase III of the study. The IDS was more frequent (36%) in phase IV than in phase I (16%); however, this increase did not reach statistical significance. The results of this study suggest that short-term BVM guided-ultrafiltration may be a useful tool to diagnose volume overload and to adjust dry weight and, consequently, to achieve a better control of BP in pediatric HD patients.
Candan
Cengiz
C
Department of Pediatric Nephrology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey. cengizcandan@hotmail.com
Sever
Lale
L
Civilibal
Mahmut
M
Caliskan
Salim
S
Arisoy
Nil
N
D000293:Adolescent; D000328:Adult; D018660:Blood Pressure Monitoring, Ambulatory; D001810:Blood Volume / Q000502:physiology*; D001835:Body Weight; D002648:Child; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D008297:Male; D008991:Monitoring, Physiologic; D006435:Renal Dialysis
J Pediatr. 1997 Feb;130(2):178-84
9042117
J Pediatr. 2002 Aug;141(2):191-7
12183713
Pediatr Nephrol. 2001 Jan;16(1):15-8
11198596
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Nephrol Dial Transplant. 2007 Dec;22(12):3547-52
17890254
Clin J Am Soc Nephrol. 2007 Mar;2(2):252-7
17699421
Nephrol Dial Transplant. 1999 Dec;14(12):2915-21
10570097
Pediatr Nephrol. 2004 Apr;19(4):432-7
14991391
Pediatr Nephrol. 2007 Apr;22(4):547-53
17115195
Pediatr Nephrol. 2003 Feb;18(2):145-9
12579404
Kidney Int. 2005 Aug;68(2):854-61
16014066
Adv Chronic Kidney Dis. 2004 Apr;11(2):134-42
15216485
Am J Kidney Dis. 1999 Apr;33(4):667-74
10196007
Artif Organs. 1998 Aug;22(8):627-32
9702312
Am J Kidney Dis. 1998 Nov;32(5):720-4
9820439
J Am Soc Nephrol. 1999 Feb;10(2):392-403
10215341
Am J Kidney Dis. 1999 Aug;34(2):218-21
10430965
Semin Dial. 2004 Jan-Feb;17(1):37-43
14717810
Nephrol Dial Transplant. 2004 Sep;19(9):2360-7
15266034
J Am Soc Nephrol. 1995 Aug;6(2):214-9
7579087
J Am Soc Nephrol. 2003 Aug;14(8):2127-31
12874467
Am J Kidney Dis. 2005 Feb;45(2):309-15
15685509
Kidney Int. 1993 Oct;44(4):851-4
8258960
Am J Kidney Dis. 2002 Feb;39(2):227-44
11840363
Adv Ren Replace Ther. 1998 Jan;5(1):64-74
9477217
Am J Kidney Dis. 1998 Nov;32(5):705-19
9820438
Pediatr Nephrol. 2008 May;23(5):813-20
18224345
Am J Kidney Dis. 1996 Apr;27(4):525-32
8678063
Adv Ren Replace Ther. 1999 Jul;6(3):233-42
10452706
Pediatr Nephrol. 2005 Aug;20(8):1054-66
15947992